title: [Brachytherapy in combination with function-preserving surgery of cancer of the paranasal sinus].
abstract: BACKGROUND
  Prognosis of patients with advanced/recurrent cancer of paranasal sinuses and orbit with infiltration of the skull base is very bad. Radical surgery does not improve prognosis. A disadvantage of the radical surgery is the functional loss and the residual cosmetic defect. We present the results of a function-preserving surgery in combination with interstitial, image adapted brachytherapy (IABT) for the treatment of these cancers.
  
  
  METHODS
  Ten patients with paranasal sinus cancer and 16 patients with sarcomas (n=26) were retrospectively analysed. After a maximum tumor resection (mostly R1-R2 resections), 2-12 flexible afterloading plastic tubes were implanted. The postoperative IABT total dose was 10-25 Gy in 2.5 Gy fractions twice daily fractions for 5 days.
  
  
  RESULTS
  In all cases the eye was obtained without functional damage. The IABT was well tolerated. The visual and cosmetic results were satisfactory. Postoperative complications occurred in 7 out of 26 cases without a serious long-term adverse event. Significant radiation-induced complications were found in patients with orbital or skull base involvement. The three years overall survival was 60% for rhabdomyosarcoma, and 33% for the paranasal sinus cancers.
  
  
  CONCLUSIONS
  These results show that a combined treatment of function-preserving surgery and a IABT is a feasible, successful and well-tolerated option for curative, salvage and palliative therapy for selected patients with advanced or recurrent carcinoma of the paranasal sinuses and orbit.
authors.affiliation: Klinik HNO-Heilkunde und plastische Operationen, UKSH Campus Lübeck. jens.meyer@uk-sh.de
authors.forename: J E
authors.initials: JE
authors.lastname: Meyer
authors.forename: C
authors.initials: C
authors.lastname: Brocks
authors.forename: P
authors.initials: P
authors.lastname: Lamcke
authors.forename: R J
authors.initials: RJ
authors.lastname: Strege
authors.forename: S
authors.initials: S
authors.lastname: Maune
authors.forename: H M
authors.initials: HM
authors.lastname: Mehdorn
authors.forename: B
authors.initials: B
authors.lastname: Wollenberg
authors.forename: G
authors.initials: G
authors.lastname: Kovacs
mesh_terms: D001918:Brachytherapy / Q000379:methods*; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery*; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D009367:Neoplasm Staging; D009915:Orbit / Q000473:pathology*; D010166:Palliative Care; D010255:Paranasal Sinus Neoplasms / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery*; D011880:Radiotherapy Planning, Computer-Assisted; D018714:Radiotherapy, Adjuvant; D012189:Retrospective Studies; D012208:Rhabdomyosarcoma / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery*; D016879:Salvage Therapy; D019291:Skull Base / Q000473:pathology*; D015996:Survival Rate